**2.10 Case report Jane**

**Focus:** implementation of MiniMed 780G 5 months after T1D diagnosis**. History:** Jane (today 28 y/o) was initially diagnosed with gestational diabetes during her third pregnancy. Till delivery (in the 34th week, November 22, 2021, girl, 1840 g, 43 cm) she was treated with insulin detemir 8 IU/d. Discharged without any antidiabetic medication [28]. In April 2022, she started to experience polydipsia, polyuria, nausea without vomiting, and anorexia with a loss of 10 kg in body mass. On May 31st, 2022 she was admitted to hospital and diagnosed with T1D (HbA1c 146 mmol/mol), put on insulin aspart, and trained in selfmonitoring by means of glucometer-strips system Galileo Glu/Ket (**Figure 25**). Although it was questionable if Jane would adapt well to having an insulin pump, the implementation of MiniMed 780G on October 31, 2022 at an out-patient clinic (with a basal insulin rate of 12.35 IU/d) proved to be a reliable method of therapy (**Table 10**, **Figures 26** and **27**).
